Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Sichuan University
Humanetics Corporation
University of Pittsburgh
Case Comprehensive Cancer Center
NYU Langone Health
Abramson Cancer Center at Penn Medicine
University of Texas Southwestern Medical Center
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
University of Alabama at Birmingham
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Indiana University
University of Alabama at Birmingham
Radiation Therapy Oncology Group
University of Alabama at Birmingham
Northwestern University